Improvements in hematologic markers and decreases in fatigue with pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and mild or moderate anemia (hemoglobin ≥10 g/dL) who had received eculizumab or were naive to complement inhibitors

Autor: Panse, Jens1,2 (AUTHOR) jpanse@ukaachen.de, Daguindau, Nicolas3 (AUTHOR), Okuyama, Sonia4 (AUTHOR), Peffault de Latour, Régis5 (AUTHOR), Schafhausen, Philippe6 (AUTHOR), Straetmans, Nicole7 (AUTHOR), Al-Adhami, Mohammed8 (AUTHOR), Persson, Emmelie9 (AUTHOR), Wong, Raymond Siu Ming10 (AUTHOR)
Zdroj: PLoS ONE. 7/29/2024, Vol. 19 Issue 7, p1-20. 20p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje